Here are five key points:
1. Aetna’s board granted the authorization on Feb. 17, 2017.
2. Aetna plans to purchase more than 20 million company shares.
3. On Feb. 22, 2017, the company said it formed accelerated buyback agreements with two dealers for almost 10.4 million shares each.
4. In late January 2017, U.S. District Judge John Bates blocked Aetna’s proposed $37 billion acquisition of Louisville, Ky.-based Humana, saying the deal would likely diminish competition in the Medicare Advantage market. Aetna owed Humana a $1 billion breakup fee as per the merger agreement.
5. Aetna shares have jumped more than 3 percent since Aetna and Humana terminated their deal.
More articles on coding & billing:
ACA enrollments could increase under Trump if Medicaid expansion remains’
The 4 secrets to scaling your business
4 interventional spine pain procedures see 16%+ lower payment in 2017
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
